Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02673398
Title Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

Her2-receptor positive breast cancer

Therapies

Neratinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.